Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
INGN

INGN - Inogen Inc Stock Price, Fair Value and News

$6.07-0.03 (-0.49%)
Market Closed

57/100

INGN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

57/100

INGN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

INGN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

INGN Price Action

Last 7 days

-6.2%

Last 30 days

-1.0%

Last 90 days

-14.0%

Trailing 12 Months

-18.5%

INGN RSI Chart

INGN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

INGN Valuation

Market Cap

165.3M

Price/Earnings (Trailing)

-7.27

Price/Sales (Trailing)

0.47

EV/EBITDA

-22.64

Price/Free Cashflow

-12.03

INGN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

INGN Fundamentals

INGN Revenue

Revenue (TTM)

348.7M

Rev. Growth (Yr)

2.05%

Rev. Growth (Qtr)

-11.55%

INGN Earnings

Earnings (TTM)

-22.7M

Earnings Growth (Yr)

26.96%

Earnings Growth (Qtr)

-34.62%

INGN Profitability

Operating Margin

44.24%

EBT Margin

-6.71%

Return on Equity

-11.83%

Return on Assets

-7.62%

Free Cashflow Yield

-8.31%

INGN Investor Care

Shares Dilution (1Y)

2.65%

Diluted EPS (TTM)

-0.86

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025340.0M343.5M347.0M348.7M
2024321.5M326.7M331.5M335.7M
2023369.0M349.3M327.9M315.7M
2022351.5M353.3M365.6M377.2M
2021306.9M336.8M355.6M358.0M
2020360.2M330.9M313.4M308.5M
2019369.3M373.1M369.6M361.9M
2018276.0M309.1M335.4M358.1M
2017212.3M221.9M236.5M249.4M
2016168.2M178.8M192.4M202.8M
2015122.7M136.3M147.7M159.0M
201483.3M93.6M103.2M112.5M
201355.3M62.0M68.7M75.4M
201200048.6M
Get all data in R, Python etc through our Historical Stock Data APIs

About Inogen Inc

INGN
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; and related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
 CEO
 WEBSITEinogen.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES1026

Inogen Inc Frequently Asked Questions

INGN is the stock ticker symbol of Inogen Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of Inogen Inc is 165.3 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Fri Mar 13 2026, INGN's PE ratio (Price to Earnings) is -7.27 and Price to Sales (PS) ratio is 0.47. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. INGN PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Inogen Inc has provided -0.175 (multiply by 100 for percentage) rate of return.